Cargando…
Non-clinical and Pre-clinical Testing to Demonstrate Safety of the Barostim Neo Electrode for Activation of Carotid Baroreceptors in Chronic Human Implants
The Barostim neo™ electrode was developed by CVRx, Inc.to deliver baroreflex activation therapy (BAT)™ to treat hypertension and heart failure. The neo electrode concept was designed to deliver electrical stimulation to the baroreceptors within the carotid sinus bulb, while minimizing invasiveness o...
Autores principales: | Wilks, Seth J., Hara, Seth A., Ross, Erika K., Nicolai, Evan N., Pignato, Paul A., Cates, Adam W., Ludwig, Kip A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539240/ https://www.ncbi.nlm.nih.gov/pubmed/28824361 http://dx.doi.org/10.3389/fnins.2017.00438 |
Ejemplares similares
-
Aortic Baroreceptors Display Higher Mechanosensitivity than Carotid Baroreceptors
por: Lau, Eva On-Chai, et al.
Publicado: (2016) -
Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2011) -
Reflex influence of carotid baroreceptor inactivation on respiratory resistance in humans
por: Klawe, JJ, et al.
Publicado: (2009) -
Carotid Baroreceptor Stimulation: A Potential Solution for Resistant Hypertension
por: Zhang, Jun, et al.
Publicado: (2014) -
Cardiopulmonary baroreceptors modify pain intensity in patients with chronic back pain
por: Iwakuma, Yuto, et al.
Publicado: (2023)